Hollsteen
← Texas Instruments

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 2016: $9.8B · 10-Q 0001564590-16-017570 filed May 4, 2016Equity incl. NCI · Q2 2016: $10.0B · 10-Q 0001564590-16-022552 filed Aug 4, 2016Equity incl. NCI · Q3 2016: $10.3B · 10-Q 0001564590-16-027067 filed Nov 3, 2016Equity incl. NCI · Q4 2016: $10.5B · 10-K 0001564590-17-002142 filed Feb 23, 2017Equity incl. NCI · Q1 2017: $10.6B · 10-Q 0001564590-17-008260 filed May 3, 2017Equity incl. NCI · Q2 2017: $10.7B · 10-Q 0001564590-17-015153 filed Aug 3, 2017Equity incl. NCI · Q3 2017: $11.0B · 10-Q 0001564590-17-021032 filed Nov 2, 2017Equity incl. NCI · Q4 2017: $10.3B · 10-K 0001564590-18-002832 filed Feb 22, 2018Equity incl. NCI · Q1 2018: $10.6B · 10-Q 0001564590-18-010545 filed May 3, 2018Equity incl. NCI · Q2 2018: $10.6B · 10-Q 0001564590-18-018753 filed Aug 2, 2018Equity incl. NCI · Q3 2018: $10.5B · 10-Q 0001564590-18-026405 filed Nov 2, 2018Equity incl. NCI · Q4 2018: $9.0B · 10-K 0001564590-19-003839 filed Feb 22, 2019Equity incl. NCI · Q1 2019: $8.5B · 10-Q 0001564590-19-014051 filed Apr 30, 2019Equity incl. NCI · Q2 2019: $8.5B · 10-Q 0001564590-19-027328 filed Jul 31, 2019Equity incl. NCI · Q3 2019: $9.0B · 10-Q 0000097476-19-000009 filed Oct 31, 2019Equity incl. NCI · Q4 2019: $8.9B · 10-K 0000097476-20-000009 filed Feb 20, 2020Equity incl. NCI · Q1 2020: $7.7B · 10-Q 0000097476-20-000017 filed Apr 22, 2020Equity incl. NCI · Q2 2020: $7.6B · 10-Q 0000097476-20-000026 filed Jul 22, 2020Equity incl. NCI · Q3 2020: $8.3B · 10-Q 0001628280-20-014630 filed Oct 21, 2020Equity incl. NCI · Q4 2020: $9.2B · 10-K 0000097476-21-000006 filed Feb 5, 2021Equity incl. NCI · Q1 2021: $10.2B · 10-Q 0000097476-21-000013 filed Apr 28, 2021Equity incl. NCI · Q2 2021: $11.2B · 10-Q 0000097476-21-000020 filed Jul 22, 2021Equity incl. NCI · Q3 2021: $12.2B · 10-Q 0000097476-21-000032 filed Oct 27, 2021Equity incl. NCI · Q4 2021: $13.3B · 10-K 0000097476-22-000009 filed Feb 4, 2022Equity incl. NCI · Q1 2022: $14.0B · 10-Q 0000097476-22-000028 filed Apr 27, 2022Equity incl. NCI · Q2 2022: $14.1B · 10-Q 0000097476-22-000040 filed Jul 27, 2022Equity incl. NCI · Q3 2022: $14.5B · 10-Q 0000097476-22-000048 filed Oct 26, 2022Equity incl. NCI · Q4 2022: $14.6B · 10-K 0000097476-23-000007 filed Feb 3, 2023Equity incl. NCI · Q1 2023: $15.2B · 10-Q 0000097476-23-000025 filed Apr 26, 2023Equity incl. NCI · Q2 2023: $15.9B · 10-Q 0000097476-23-000035 filed Jul 26, 2023Equity incl. NCI · Q3 2023: $16.6B · 10-Q 0000097476-23-000041 filed Oct 25, 2023Equity incl. NCI · Q4 2023: $16.9B · 10-K 0000097476-24-000007 filed Feb 2, 2024Equity incl. NCI · Q1 2024: $17.0B · 10-Q 0000097476-24-000021 filed Apr 24, 2024Equity incl. NCI · Q2 2024: $17.2B · 10-Q 0000097476-24-000030 filed Jul 24, 2024Equity incl. NCI · Q3 2024: $17.3B · 10-Q 0000097476-24-000042 filed Oct 23, 2024Equity incl. NCI · Q4 2024: $16.9B · 10-K 0000097476-25-000007 filed Feb 14, 2025Equity incl. NCI · Q1 2025: $16.4B · 10-Q 0000097476-25-000027 filed Apr 24, 2025Equity incl. NCI · Q2 2025: $16.4B · 10-Q 0000097476-25-000036 filed Jul 29, 2025Equity incl. NCI · Q3 2025: $16.6B · 10-Q 0000097476-25-000060 filed Oct 23, 2025Equity incl. NCI · Q4 2025: $16.3B · 10-K 0000097476-26-000059 filed Feb 6, 2026Equity incl. NCI · Q1 2026: $16.8B · 10-Q 0000097476-26-000101 filed Apr 24, 2026Equity incl. NCI · Q2 2026: $18.0B · 10-Q 0000097476-26-000152 filed Jul 24, 202616.318.09.8Q1 2016Q2 2026
Q4 2025
16.3$B
All values (42)
PeriodValue ($B)Status
Q2 202618.0reported
Q1 202616.8reported
Q4 202516.3reported
Q3 202516.6reported
Q2 202516.4reported
Q1 202516.4reported
Q4 202416.9reported
Q3 202417.3reported
Q2 202417.2reported
Q1 202417.0reported
Q4 202316.9reported
Q3 202316.6reported
Q2 202315.9reported
Q1 202315.2reported
Q4 202214.6reported
Q3 202214.5reported
Q2 202214.1reported
Q1 202214.0reported
Q4 202113.3reported
Q3 202112.2reported
Q2 202111.2reported
Q1 202110.2reported
Q4 20209.2reported
Q3 20208.3reported
Q2 20207.6reported
Q1 20207.7reported
Q4 20198.9reported
Q3 20199.0reported
Q2 20198.5reported
Q1 20198.5reported
Q4 20189.0reported
Q3 201810.5reported
Q2 201810.6reported
Q1 201810.6reported
Q4 201710.3reported
Q3 201711.0reported
Q2 201710.7reported
Q1 201710.6reported
Q4 201610.5reported
Q3 201610.3reported
Q2 201610.0reported
Q1 20169.8reported

CSV with all sources · Technical ID: equity_total

More metrics for Texas Instruments
Sources & calculation
Value
$16.3B
Period
Q4 2025, ended Dec 31, 2025 · as of Dec 31, 2025 (balance as of date, not a sum)
Source
10-K, filed Feb 6, 2026 · 0000097476-26-000059
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$16.3BFeb 6, 202610-K 0000097476-26-000059reported · confidence 1. · current